Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
Clinical trial NCT01188967 · COMPLETED
Trial details
- NCT number
- NCT01188967
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-05-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.